- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/10 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Patent holdings for IPC class C07K 16/10
Total number of patents in this class: 5167
10-year publication summary
|
272
|
248
|
286
|
295
|
309
|
488
|
599
|
558
|
472
|
141
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
141 |
| Humabs Biomed SA | 122 |
84 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
83 |
| Vanderbilt University | 1887 |
76 |
| The Rockefeller University | 565 |
74 |
| The Scripps Research Institute | 1346 |
73 |
| Duke University | 3058 |
64 |
| VIR Biotechnology, Inc. | 143 |
55 |
| California Institute of Technology | 3967 |
47 |
| The Wistar Institute of Anatomy and Biology | 448 |
44 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
40 |
| Institut Pasteur | 789 |
38 |
| The Trustees of Columbia University in the City of New York | 3558 |
37 |
| The Trustees of the University of Pennsylvania | 4308 |
35 |
| Academia Sinica | 935 |
35 |
| International AIDS Vaccine Initiative | 89 |
34 |
| Visterra, Inc. | 129 |
33 |
| The Regents of the University of California | 19812 |
30 |
| Genmab A/S | 412 |
30 |
| MedImmune Limited | 611 |
28 |
| Other owners | 4086 |